Patients enrolled in the parent study who were seropositive for the hepatitis B surface antigen and had normal liver function , serum HBV DNA levels of less than @ copies/mL , and no prior antiviral therapy were randomized to entecavir ( n = @ ) or lamivudine ( n = @ ) .